$JDBullishMed

10 Best Asian Stocks with Huge Upside Potential

The article highlights Asian equities’ “hidden value,” citing AllianceBernstein’s view that earnings recovery is not fully priced and projecting 52.3% earnings growth for 2026, with Asia ex Japan trading at a 32% MSCI World discount. It also notes support from AI/EV/robotics/semiconductors. Examples: JD.com reported Q1 revenue of $45.8B; BofA raised its target to $37 and Barclays to $43. KE Holdings posted Q1 adjusted EPS of RMB1.42 and revenue of RMB18.9B; BofA raised its target to $23 and Barc

7/10
5/10
Med
Bullish
Post-earnings/analyst-revision window (after May 2026 Q1 updates).
Bullish—focus on earnings recovery, AI/tech supply-chain support, and raised targets.

Near-term upside bias from earnings momentum and bullish sell-side revisions; job-protection messaging may reduce AI-related sentiment risk.

Article highlights JD.com Q1 revenue/earnings beat plus multiple analyst price-target raises and a pledge to protect jobs amid AI automation.

Moderately positive drift possible as analyst target hikes and Q1 beats reinforce momentum; headline risk from automation/job narratives remains.

Background

The article is a curated list of 10 Asian stocks screened for ≥30% upside to analysts’ median price targets, with a stated preference for names that recently reported sentiment-impacting developments.

Why it matters

For JD and BEKE, the actionable elements are the cited Q1 results and subsequent analyst target increases; the AI/job-protection angle for JD adds a sentiment-risk dimension.

Market relevance

This is primarily a sentiment/positioning piece, but it contains concrete earnings beats and sell-side revisions for two named US-listed companies.

Market effects

Reinforces the narrative that Asia earnings recovery and AI/tech capex themes are driving valuation support; could lift sentiment for China consumer/real-estate platforms.

Supports a broader risk-on tilt toward Asia ex-Japan equities via earnings-growth and valuation-discount framing.

May marginally influence global EM/Asia allocation flows, but the article is stock-specific rather than a macro shock.

Alternative perspectives

Upside case is partly valuation/analyst-target driven; China demand/property-cycle risks could cap follow-through even after one-quarter beats.

The article’s “huge upside” framing is methodology-driven (30% target upside) and may underweight execution risk, regulatory risk, and the durability of margin improvements.

Key entities

  • JD.com, Inc.

    Q1 revenue/operating momentum plus analyst target hikes; founder messaging on AI automation and job protection.

  • KE Holdings Inc.

    Q1 adjusted EPS/profit beat, margin improvement, share repurchase, and analyst target increases.

Related articles

$AMZNMed

Fortune Tech: Trump AI order, DeepSeek fundraise, Microsoft AI models

Fortune Tech highlights major U.S. company rankings, with Amazon taking the top spot and Microsoft rising to its highest-ever rank at No. 11. Separately, Reuters reports China’s DeepSeek is nearing a first funding round of about 50 billion yuan (~$7.4B), valuing it at 350–400 billion yuan ($52–$59B), with investors including Tencent and CATL. Microsoft also unveiled MAI-Thinking-1, its first advanced reasoning model, in private preview.

$JDMed

DeepSeek slated to draw $7 billion in maiden fundraising, sources say

Chinese AI startup DeepSeek is reportedly set to raise about 50 billion yuan ($7.4 billion) in its first funding round, with investors including Tencent Holdings and CATL, according to people familiar with the matter. The round could value the company at 350–400 billion yuan ($52–$59 billion). Founder Liang Wenfeng plans to invest 20 billion yuan; Tencent and CATL are considering 10 billion and 5 billion yuan, respectively.

$MPNGFMedAI 9/10

Meituan Loss Shrinks To 6.5 Billion Yuan As Subsidy War Cools

Meituan reported a March-quarter operating loss of 6.5 billion yuan (~$961 million), smaller than an average analyst estimate of about 9 billion yuan, while revenue rose 5.6% to 91 billion yuan. The company said subsidy intensity is easing but order growth may slow in the second half due to 2025 comparisons. Meituan faces ongoing food-delivery antitrust scrutiny and plans to expand overseas via Keeta.